These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1588522)

  • 21. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
    Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
    J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An ongoing immune response to HIV envelope gp120 in human CD4-transgenic mice contributes to T cell decline upon intravenous administration of gp120.
    Kang Y; Melo EF; Scott DW
    Eur J Immunol; 1998 Aug; 28(8):2253-64. PubMed ID: 9710203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternally induced graft-vs-host disease to minor antigens as a possible etiology of an acquired immunodeficiency syndrome in mice.
    Hamilton MS; Becker J; Hamilton BL
    Cancer Detect Prev; 1988; 12(1-6):205-10. PubMed ID: 3180124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Programmed death (apoptosis) of T CD4 lymphocytes and AIDS pathogenesis].
    Ameisen JC; Groux H; Capron A
    C R Acad Sci III; 1992; 314(9 Suppl):47-50. PubMed ID: 1358412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
    Cohen S; Tuen M; Hioe CE
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis.
    De Rossi A; Calabro ML; Panozzo M; Bernardi D; Caruso B; Tridente G; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):287-98. PubMed ID: 1692721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New concepts in AIDS pathogenesis.
    Gougeon ML; Colizzi V; Dalgleish A; Montagnier L
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):287-9. PubMed ID: 8471320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human genes other than CD4 facilitate HIV-1 infection of murine cells.
    Weiner DB; Huebner K; Williams WV; Greene MI
    Pathobiology; 1991; 59(6):361-71. PubMed ID: 1930688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL.
    Root-Bernstein RS; DeWitt SH
    Genetica; 1995; 95(1-3):133-56. PubMed ID: 7744257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
    Wang ZQ; Orlikowsky T; Dudhane A; Mittler R; Blum M; Lacy E; Riethmüller G; Hoffmann MK
    Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance.
    Miedema F
    Immunodefic Rev; 1992; 3(3):173-93. PubMed ID: 1354968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of human immunodeficiency virus.
    McKallip RJ; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):53-62. PubMed ID: 7878678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
    J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK; Sieh M; Pious DA; Reinherz EL
    Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-assessing the virological approach to HIV pathogenesis: can it explain AIDS as an immunological disease?
    Whitaker RE
    J Theor Biol; 1997 Jul; 187(1):45-56. PubMed ID: 9236107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
    J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.